Acquisition of such genetic alteration transforms a normal Lin–CD34+CD38– HSC into a CML-initiating cell/leukemia stem cell, with a proliferative advantage and bias toward myeloid differentiation (62, 150). This evidence concerns the gene CD34 and leukemia.